Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

18.45
Delayed Data
As of Jun 21
 +0.02 / +0.11%
Today’s Change
16.63
Today|||52-Week Range
33.30
-9.74%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close18.43
Today’s open18.57
Day’s range18.28 - 18.68
Volume654,100
Average volume (3 months)253,761
Market cap$646.0M
Dividend yield--
Data as of 06/21/2017

Growth & Valuation

Earnings growth (last year)-168.25%
Earnings growth (this year)-124.37%
Earnings growth (next 5 years)--
Revenue growth (last year)-8.90%
P/E ratioNM
Price/Sales7.72
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
PRTKParatek Pharmaceutic...+0.25+1.07%
RETAReata Pharmaceutical...-0.05-0.17%
BYSIBeyondspring Inc-1.59-5.02%
CARACara Therapeutics In...+1.81+10.23%
Data as of 06/21/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$91.9M
Annual profit (last year)-$58.5M
Net profit margin-63.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
Senior VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts